Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

Published 12/09/2022, 16:08
Updated 12/09/2022, 16:40
© Reuters.  Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

© Reuters. Livent, Amgen And Some Other Big Stocks Moving Lower On Monday

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.

  • DICE Therapeutics, Inc. (NASDAQ: DICE) fell 19.6% to $18.20. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
  • Entrada Therapeutics, Inc. (NASDAQ: TRDA) dropped 11.4% to $13.21. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • ShiftPixy, Inc. (NASDAQ: PIXY) fell 9.8% to $31.06 after gaining 11% on Friday.
  • Azure Power Global Limited (NYSE: AZRE) dropped 9.3% to $5.32.
  • Immatics N.V. (NASDAQ: IMTX) fell 9% to $11.69.
  • Microvast Holdings, Inc. (NASDAQ: MVST) declined 8.3% to $2.3197.
  • Construction Partners, Inc. (NASDAQ: ROAD) fell 7.8% to $28.00.
  • Forge Global Holdings, Inc. (NYSE: FRGE) dropped 7.8% to $4.04.
  • Burning Rock Biotech Limited (NASDAQ: BNR) declined 7.2% to $3.33.
  • Humacyte, Inc. (NASDAQ: HUMA) fell 7.1% to $4.19. Humacyte recently filed for mixed-securities shelf offering of up to $300 million.
  • Couchbase, Inc. (NASDAQ: BASE) dipped 7.1% to $14.49. The company, last week, posted upbeat quarterly results.
  • Livent Corporation (NYSE: LTHM) fell 5.8% to $32.46 after Verticle Research downgraded the stock from Buy to Hold and announced a $35 price target.
  • Amgen Inc . (NASDAQ: NASDAQ:AMGN) dropped 3.7% to $238.44 following FDA approval of Bristol Myers Squibb's plaque psoriasis drug Sotyktu, which showed superior efficacy to Amgen's Otezla.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.